iposomal azithromycin in cotaneous leishmaniasis

Phase 3

• Conditions: eishmaniasis.; L00-L08; Infections

• Registration Number: IRCT20180425039414N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

New cases of cutaneous leishmaniasis
1-5 lesions with 3 cm and diameter more than 3 cm

Exclusion Criteria

More than 5 lesions
Lesions on face, neck, joint and mucosal sites or sporotrichoid like lesions
Lung surface size is more than 5 Square centimeters
The patient is pregnant or breastfeeding.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eishmaniasis. Timepoint: 6 weeks, 12 weeks and 6 months after treatment. Method of measurement: Digital photography.

Secondary Outcome Measures

Name	Time	Method
-. Timepoint: -. Method of measurement: -.